71 unknown. 71 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 71 | Unknown 71 |
Follow Lymphoproliferative Disorders: new trials by email Literature Review of Lymphoproliferative Disorders trials Research Report on Lymphoproliferative Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation Pentaisomaltose - Malignant Lymphoma, Multiple Myeloma | Phase 4 | Unknown | Pharmacosmos A/S | 150 | 2024-04-30 | 2024-04-03 |
| Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients Tocilizumab - Multiple Myeloma | Phase 4 | Unknown | The First Affiliated Hospital of Soochow University | 48 | 2023-04-17 | 2023-06-02 |
| Selinexor Combined With R-GemOx as Second-line Treatment in Patients With Diffuse Large B-cell Lymphoma selinexor - Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Phase 4 | Unknown | Chongqing University Cancer Hospital | 32 | 2023-02-28 | 2023-03-28 |
| Plerixafor for Poorly Mobilized Lymphoma Plerixafor,G-CSF - Lymphoma | Phase 4 | Unknown | Peking University | 140 | 2022-12-19 | 2023-03-13 |
| Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma Pentoxifylline, Placebo - Hodgkin Lymphoma | Phase 4 | Unknown | University of Guadalajara | 30 | 2022-07-11 | 2023-04-18 |
| Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis 25(OH)D3, vitamin D3 - Multiple Sclerosis, Relapsing-Remitting, Adult ALL | Phase 4 | Unknown | Tehran University of Medical Sciences | 54 | 2022-07-01 | 2022-04-22 |
| The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN) Venlafaxine - Major Depressive Disorder, Bipolar Affective Disorder, Currently Depressed, Moderate | Phase 4 | Unknown | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 30 | 2022-03-01 | 2023-11-14 |
| Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells PEG-rhG-CSF, RhG-CSF - Lymphoma | Phase 4 | Unknown | Chongqing University Cancer Hospital | 174 | 2022-03-01 | 2023-09-07 |
| Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD Bortezomib - Acute Lymphoblastic Leukemia, in Relapse, Chemotherapeutic Toxicity | Phase 4 | Unknown | Hospital General de Mexico | 56 | 2021-12-12 | 2022-01-18 |
| Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia Simvastatin - Strains, Acute Lymphoblastic Leukemia | Phase 4 | Unknown | Hospital General de Mexico | 108 | 2021-11-19 | 2022-01-04 |
| Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study RiTUXimab Injection [Truxima] - Non-Hodgkin's Lymphoma | Phase 4 | Unknown | Laida Cuevas Palomares | 48 | 2021-09-28 | 2022-03-31 |
| Study of Pomalidomide, Oral Dexamethasone and Ixazomib in Patients With Relapsed MM Who Have Received Lenalidomide Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone - Multiple Myeloma | Phase 4 | Unknown | Peking Union Medical College Hospital | 60 | 2021-07-26 | 2021-08-19 |
| Rituximab Maintenance Treatment of Newly Diagnosed Follicular Lymphoma After BR or RCHOP or R2: a Multicenter Clinical Study BR for 6 cycles +R for 8 cycles, RCHOP for 6 cycles +R for 8 cycles, R2 for 6 cycles + R2 maintenance - Follicular Lymphoma | Phase 4 | Unknown | Ruijin Hospital | 789 | 2021-03-01 | 2021-04-13 |
| Effectiveness of Methotrexate Versus Prednisone as First-line Therapy for Pulmonary Sarcoidosis Methotrexate, Prednisone - Sarcoidosis, Pulmonary | Phase 4 | Unknown | Erasmus Medical Center | 138 | 2020-06-01 | 2025-03-26 |
| Effectiveness, Tolerability and Safety of Three Formulations in Underfives With Moderate Acute Malnutrition Standardized milk-based formulation - Malnutrition; Moderate | Phase 4 | Unknown | Dr. Ekong E. Udoh | 80 | 2020-04-01 | 2020-03-30 |
| Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis Thalidomide, Cyclophosphamide - Immunoglobulin Light-Chain Amyloidosis | Phase 4 | Unknown | Guangdong Provincial People's Hospital | 70 | 2020-01-01 | 2020-11-03 |
| Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL PD-1 combined with chemotherapy, chemotherapy - Relapsed/Refractory Non-Hodgkin's Lymphoma | Phase 4 | Unknown | Shandong Provincial Hospital | 120 | 2019-11-01 | 2019-10-22 |
| PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma PD-1 blocking antibody, chidamide, lenalidomide and gemcitabine - Peripheral T-cell Lymphoma | Phase 4 | Unknown | Mingzhi Zhang | 100 | 2019-09-01 | 2020-05-12 |
| Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in Lymphoma PEG-rhG-CSF, rhG-CSF - Lymphoma, Non-Hodgkin, Granulocyte Colony-Stimulating Factor | Phase 4 | Unknown | Ruijin Hospital | 250 | 2019-08-01 | 2019-09-10 |
| R2 and Combination Chemotherapy Versus R and Combination Chemotherapy in Newly Diagnosed Highly Aggressive B-NHL R2-combination chemotherapy, R-combination chemotherapy - Lymphoma, B-Cell | Phase 4 | Unknown | Shandong Provincial Hospital | 200 | 2019-06-05 | 2019-11-05 |
Showing 20 of 71. Sign in to see all of them.
Precursor Cell Lymphoblastic Leukemia-Lymphoma (17) · Lymphoma (13) · Multiple Myeloma (8) · Lymphoma, Follicular (7) · Lymphoma, Non-Hodgkin (7) · Lymphoma, Large B-Cell, Diffuse (5) · Lymphoma, T-Cell, Peripheral (4) · Sarcoidosis (4) · Leukemia (3) · Lymphoma, B-Cell (3) · Sarcoidosis, Pulmonary (3) · Hematologic Neoplasms (2) · Hepatitis B (2) · Hodgkin Disease (2) · Lymphoma, T-Cell (2)
Hemic and Lymphatic Diseases (70) · Immune System Diseases (70) · Neoplasms by Histologic Type (65) · Immunoproliferative Disorders (64) · Neoplasms (64) · Lymphatic Diseases (63) · Hematologic Diseases (31) · Lymphoma (28) · Lymphoma, Non-Hodgkin (19) · Leukemia, Lymphoid (18) · Leukemia (17) · Cardiovascular Diseases (10) · Vascular Diseases (10) · Neoplasms, Plasma Cell (9)
Cyclophosphamide (9) · Dexamethasone (8) · Methotrexate (6) · Vincristine (6) · Doxorubicin (5) · Bortezomib (4) · Cytarabine (4) · Mercaptopurine (4) · Prednisone (4) · Rituximab (4) · pegylated granulocyte colony-stimulating factor (4) · Etoposide (3) · Granulocyte Colony-Stimulating Factor (3) · Idarubicin (3) · Ifosfamide (3)
Peking University (7) · Mingzhi Zhang (5) · Shandong Provincial Hospital (5) · Ruijin Hospital (4) · University of Cincinnati (4) · Chongqing University Cancer Hospital (2) · Hospital General de Mexico (2) · PETHEMA Foundation (2) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (2) · Sun Yat-sen University (2) · The First Affiliated Hospital of Soochow University (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Central Hospital, Nancy, France (1) · Chinese Academy of Medical Sciences (1) · Dr. Ekong E. Udoh (1)
China (38) · United States (5) · Italy (3) · Mexico (3) · Spain (3) · Denmark (2) · Netherlands (2) · Switzerland (2) · France (1) · Germany (1) · Hong Kong (1) · Malaysia (1) · Nigeria (1) · Singapore (1) · South Korea (1)
Robert P Baughman, MD (4) · Jun Zhu (3) · Adolfo Martinez Tovar, PhD (2) · Jun Zhu, MD (2) · Ajay Vora (1) · Allen Yeoh, MBBS (1) · Blessing N Nwazuluoke, BSc (1) · Bor-Sheng Ko, PhD (1) · Changgang Li, M.D. (1) · Christina Peters, Prof. MD PhD (1) · Dongbo Lai, M.D. (1) · Ekong E Udoh, FWACPaed (1) · Fang Yongjun, Ph.D (1) · Franco Locatelli, Prof. MD PhD (1)
PMID 11863096, PMID 14585365, PMID 16648042, PMID 17410187, PMID 18240234, PMID 18626005, PMID 19167677, PMID 19219604, PMID 19951974, PMID 20660832, PMID 22677206, PMID 22966847, PMID 23383989, PMID 23590801, PMID 23615461, PMID 23753028, PMID 25153486, PMID 25934708, PMID 26230956, PMID 27686365, PMID 28116786, PMID 28353116, PMID 29155058, PMID 29437609, PMID 29610030, PMID 29654631, PMID 30044693, PMID 30872105, PMID 30881137, PMID 30957229, PMID 32487143, PMID 32519032, PMID 32589977, PMID 33076885, PMID 33148342, PMID 33202794, PMID 33764240, PMID 34222013, PMID 34363816, PMID 34744427, PMID 35714315, PMID 37276496, PMID 37403255, PMID 37463687, PMID 40387020, PMID 7477169, PMID 7581076
2005 (1), 2009 (1), 2019 (1)